Spanish Linguistic Validation, Validity and Reliability Test of Frail´BESTest in Elderly Institutionalized Frail People
NCT ID: NCT06438718
Last Updated: 2026-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
83 participants
OBSERVATIONAL
2024-04-01
2025-11-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The frailty syndrome, although common with aging, is not inevitable and is characterized by the loss of functional capacity and increased risk of falls and hospitalization. To assess this capacity in frail individuals, specific tools like the Mini-Motor Test, the Morton Mobility Index, and the Elderly Mobility Scale exist. The BESTest, developed in 2009, evaluates balance but is time-consuming to administer, leading to the creation of a shorter version, the Mini BESTest. However, both can be limiting for frail individuals.
To address these limitations, the Frail'BESTest was developed, evaluating six balance subsystems and being suitable for frail individuals, making it a valid and sensitive tool in clinical practice. This research project aims to develop tools that identify balance problems in frail individuals with mild cognitive impairment, allowing for specific interventions to reduce the risk of falls.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of a Daily Cognition Training in Older Adults Without Cognitive Impairment
NCT05688163
Validation of acceXible's Automated Speech Analysis Method for the Early Detection and Monitoring of Patients With Mild Impairment or Dementia in Primary Care
NCT05380297
Ageing and Health. Spanish Longitudinal Study
NCT03343886
Evaluation of Cognitive Impairment in the Elderly Admitted to Nursing Homes
NCT05404152
Clinical Intervention in Frail Older People (FRAILCLINIC)
NCT02643069
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In a second phase of the study, the validity and reliability of the test will be analysed in frail institutionalised people with mild cognitive impairment. For this purpose, frail people with mild cognitive impairment (group B) and frail people with no cognitive impairment (group C), all of them over 65 years of age, will be selected.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Validation group
This Cross-sectional study consists of five phases. PHASE 1 \[T1\] Consist on the linguistic validation and it will be carried out the transcultural adaptation of Frail'BESTest in a population sample (named group A), which will be made up of 30 individuals over 60 years of age, community living independently in their houses, cognition preserved, who have a preserved physical functional status, and able to stand up still, without assistive devices for 10s or over (Group A).
PHASE 2 \[T2\] consist on reliability. One subgroup (GROUP B and GROUP C) of institutionalized frail aged participants, n=30 with mild cognitive impairment (named group B) and 30 without mild cognitive impairment (named group C) will be tested. We will examine between raters reliability and test-retest reliability.
PHASE 3 \[T3\] consisting on construct validity. PHASE 4 \[T4\] consisting on predictive falls/concurrent validity. PHASE 5 \[T4\] consisting on predictive decease/concurrent validity.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Frailty will be determine by Fried phenotype Those scoring 3 or more out of 5 will be classify as frail and those scoring 2 or less as non-frail individuals. Mini-Mental State Examination (MMSE) cognition status could be preserved or altered (Score \>24-30).
* Community living individuals will be non-frail and cognition should preserved they will be assign to Group A.
* Frail institutionalized individual's (scoring from 24 to 26 at MMSE) will be assign to Group B Frail institutionalized individual's (scoring = or \> to 27 at MMSE) will be assign to Group C Non frail Institutionalized individuals with cognition preserved (scoring = or \> to 27 at MMSE) will be assign to group D.
Exclusion Criteria
* Moderate or severe cognitive status Score \<24 at MMSE
* Inability to understand indications or communicate with testers.
* Sustaining severe cardiac, vascular or respiratory diseases or conditions that contraindicate physical activity
* Presenting a condition for which, in the opinion of the researchers, the evaluation may pose a risk to their health
* Not having autonomy to decide about their voluntary participation in the study
60 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Investigación Sanitaria Aragón
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sandra Calvo Carrión
PhD in Health Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
María del Pilar Domínguez Oliván, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidad de Zaragoza
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad de Zaragoza
Zaragoza, Zaragoza, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Validation Frail´BESTest
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.